Home › Funds › Royce & Associates › GLUE
Royce & Associates position in GLUE
MONTE ROSA THERAPEUTICS INC · Health Care
Latest position (Q3 2025)11.02K sh
Reported value held$81.69K
Portfolio Weight0.00%
First reportedQ2 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 10.18K | $45.89K | New |
| Q3 2025 | 11.02K | $81.69K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GLUE
- BlackRock Inc 6.84M sh · $165.60M · Q2 2026
- Vanguard Group 3.25M sh · $50.91M · Q4 2025
- Geode Capital Management 1.86M sh · $45.12M · Q2 2026
- Marshall Wace 1.59M sh · $38.57M · Q2 2026
- Goldman Sachs Group 998.25K sh · $24.16M · Q2 2026
- Fidelity Management & Research (FMR) 934.41K sh · $22.61M · Q2 2026
- Morgan Stanley 789.54K sh · $19.11M · Q2 2026
- Northern Trust Corp 652.09K sh · $15.78M · Q2 2026
- Charles Schwab Investment Management 616.31K sh · $14.91M · Q2 2026
- AQR Capital Management 520.65K sh · $12.60M · Q2 2026
- Janus Henderson Group 685.93K sh · $11.29M · Q1 2026
- Bank of America Corp 254.56K sh · $6.16M · Q2 2026